Nanomedicine News

RSS

FDA Accepts EnGeneIC’s IND for EGFR-Targeted Nanocells Carrying Doxorubicin to Treat Recurrent Glioma

EnGeneIC Ltd., a clinical stage biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's investigational new drug (IND) application for using (EGFR)-EDVs loaded with doxorubicin (dox) in patients with recurrent glioma.

18 Sep 2015

Coated Silica Nanoparticles Could be used for Restorative Treatment of Sensitive Teeth

Researchers at the University of Birmingham have shown how the development of coated silica nanoparticles could be used in restorative treatment of sensitive teeth and preventing the onset of tooth decay.

18 Sep 2015

Platelet-Mimicking Nanoparticles Could Effectively Deliver Drugs to Targeted Sites

Nanoparticles disguised as human platelets could greatly enhance the healing power of drug treatments for cardiovascular disease and systemic bacterial infections. These platelet-mimicking nanoparticles, developed by engineers at the University of California, San Diego, are capable of delivering drugs to targeted sites in the body -- particularly injured blood vessels, as well as organs infected by harmful bacteria.

18 Sep 2015

NSF Awards UCLA $1 Million Grant for Quantification and Automated Characterization of Nanoparticles

Researchers at the UCLA Henry Samueli School of Engineering and Applied Science and California NanoSystems Institute (CNSI) have won a $1 million, three-year grant from the National Science Foundation for on-site and ubiquitous quantification and automated characterization of nanoparticles found in homes, workplaces and the environment.

From University of California, Los Angeles 18 Sep 2015

Novel Technique for Real-Time Observation of Bloodstream Protein Interactions with Nanoparticles

Technique developed by NUS-led team provides more precise understanding of how proteins in the bloodstream bind to nanoparticles, paving the way for better design of nanomedicines

18 Sep 2015

Researchers Secure €3.3 Million Funding to Develop Enhanced Nanoparticle Treatment Programme for Pancreatic Cancer

Researchers at the University at Buffalo, Dublin City University and Queen’s University Belfast have secured over €3.3 million to develop an enhanced treatment programme for pancreatic cancer, the fourth leading cause of cancer deaths in the world.

16 Sep 2015

Onxeo Seeks Patent for Livatag Liver Cancer Orphan Oncology Product

Onxeo S.A., an innovative biopharmaceutical company specialized in the development of drugs for orphan oncology diseases, today announced that it has filed an international patent application to protect the overall compound related to its primary liver cancer orphan oncology product Livatag®. The patent application has been filed in the US and Europe and will be expanded to include other regions, including the Asian territories, under the patent review procedure. If granted, this patent would protect Livatag® until 2036.

16 Sep 2015

Novavax RSV F-Protein Recombinant Nanoparticle Vaccine Candidate Highly Immunogenic in Preclinical Maternal Immunization Model

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced its RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) was shown to be highly immunogenic in a guinea pig model of maternal immunization. The preclinical study was published in the journal Vaccine.

From Novavax Inc. 16 Sep 2015

Global Nanomedicine Market Estimated to Grow at 12.3% CAGR During 2013 to 2019

Transparency Market Research (TMR) has recently published a market study based on the global nanomedicine market, estimating the market to grow at a healthy CAGR of 12.3% during the period from 2013 to 2019 in order to reach US$177.60 billion by 2019.The study, titled "Nanomedicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", reports that the global nanomedicine market stood at US$78.54 billion in 2012.

16 Sep 2015

Kettering to Acquire High-Resolution TEM for Nanoscale Imaging with NSF-MRI Grant

Dr. Ronald J. Tackett, faculty member in the Kettering University department of Physics, along with collaborators from multiple disciplines across campus have been awarded a National Science Foundation - Major Research Instrumentation (NSF-MRI) grant for $452,000. The grant will allow Tackett to acquire a high-resolution transmission electron microscope (TEM) with energy dispersive spectroscopy capabilities to support ongoing investigations and potentially advance materials science and nanotechnology research and teaching at Kettering.

15 Sep 2015

Nanomedicine News

FDA Accepts EnGeneIC’s IND for EGFR-Targeted Nanocells Carrying Doxorubicin to Treat Recurrent Glioma

Coated Silica Nanoparticles Could be used for Restorative Treatment of Sensitive Teeth

Platelet-Mimicking Nanoparticles Could Effectively Deliver Drugs to Targeted Sites

NSF Awards UCLA $1 Million Grant for Quantification and Automated Characterization of Nanoparticles

Novel Technique for Real-Time Observation of Bloodstream Protein Interactions with Nanoparticles

Researchers Secure €3.3 Million Funding to Develop Enhanced Nanoparticle Treatment Programme for Pancreatic Cancer

Onxeo Seeks Patent for Livatag Liver Cancer Orphan Oncology Product

Novavax RSV F-Protein Recombinant Nanoparticle Vaccine Candidate Highly Immunogenic in Preclinical Maternal Immunization Model

Global Nanomedicine Market Estimated to Grow at 12.3% CAGR During 2013 to 2019

Kettering to Acquire High-Resolution TEM for Nanoscale Imaging with NSF-MRI Grant

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Brain-Inspired Nano-Tech Promises New Era for Electronics

Nanopore-Based Sensor Enables Rapid and Precise Disease Diagnosis

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials